| Active Not Recruiting | First-in-Human Trial of the Novel Tuberculosis Vaccine Candidate, H107e/CAF®10b Healthy | Phase 1 | 2024-03-14 |
| Completed | Safety and Immunogenicity of a Chlamydia Vaccine CTH522 Trachoma | Phase 1 | 2020-02-17 |
| Completed | Immunogenicity and Safety of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given as a Booster at Age 15-18 Poliomyelitis | Phase 3 | 2018-05-15 |
| Completed | Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine Given at 6, 10, 14 Weeks and 9 Poliomyelitis | Phase 3 | 2017-02-06 |
| Completed | Safety and Immunogenicity of Adjuvanted Reduced Dose Inactivated Polio Vaccine in 2, 4, 6 Months of Age Poliomyelitis | Phase 3 | 2017-01-19 |
| Completed | Safety of Chlamydia Vaccine CTH522 in Healthy Women Aged 18 to 45 Years Chlamydia Trachomatis | Phase 1 | 2016-07-01 |
| Unknown | Infection and Adverse Pregnancy Outcome Preterm Birth | — | 2015-09-01 |
| Completed | 3 Adjuvated Reduced Dose IPV-Al SSI and Non-adjuvated Full Dose IPV SSI Given as Primary Vaccinations to Infan Poliomyelitis | Phase 2 | 2015-02-01 |
| Completed | 3 Adjuvated Reduced Dose IPV-Al SSI Vaccines and Non-adjuvated Full Dose IPV SSI, as Booster Vaccination to Ad Immunization, Booster | Phase 1 / Phase 2 | 2014-11-13 |
| Completed | Safety Study Investigating if Concomitant Injections of C-Tb and 2 T.U Tuberculin Affect Induration Responses Tuberculosis | Phase 2 / Phase 3 | 2013-10-01 |
| Completed | Pneumococcal Vaccination of Crohn Patients Crohns Disease | Phase 4 | 2013-07-01 |
| Completed | A Trial in Subjects Suspected to Have Tuberculosis, Comparing the Diagnostic Performance of C-Tb to QuantiFERO Tuberculosis | Phase 3 | 2012-09-01 |
| Completed | Comparison of Diagnostic Performance of C-Tb to QuantiFERON®-TB, in Combination With a Safety Assessment of C- Tuberculosis | Phase 3 | 2012-07-01 |
| Completed | Treatment Study of Metronidazole to Treat Dientamoebiasis in Children Dientamoebiasis | Phase 4 | 2011-07-01 |
| Completed | A Trial of the C-Tb Skin Test, When Given Intradermally to Adult Patients Recently Diagnosed With Active Tuber Tuberculosis | Phase 2 | 2011-04-01 |
| Completed | A Trial of the C-Tb Skin Test, When Given Intradermally to Healthy Volunteers Previously Vaccinated With BCG Tuberculosis | Phase 2 | 2011-04-01 |
| Completed | A Safety and Dose Finding Trial of C-Tb, When Given to Adult Patients Recently Diagnosed With Active Tuberculo Tuberculosis | Phase 1 | 2010-01-01 |
| Completed | Immunogenicity and Safety of Tetanus, Diphtheria and Mono Component Acellular Pertussis (TdaP) Vaccine in Comp Healthy | Phase 3 | 2010-01-01 |
| Completed | Trial on the Safety of a New Liposomal Adjuvant System, CAF01, When Given With the Tuberculosis Subunit Vaccin Tuberculosis | Phase 1 | 2009-10-01 |
| Completed | HIV-1 Peptide Immunisation of Individuals in West Africa to Prevent Disease Aids, Cdc Group I | Phase 1 | 2009-08-01 |
| Completed | A Safety and Immunogenicity Trial With an Adjuvanted TB Subunit Vaccine (Ag85B-ESAT-6 + IC31) Tuberculosis | Phase 1 | 2008-12-01 |
| Completed | Safety and Risk of Sensitisation of the rdESAT-6 + rCFP-10 Skin Test Following Repeated Intradermal Administra Tuberculosis | Phase 1 | 2008-11-01 |
| Completed | Infectious Causes of Uveitis Uveitis | — | 2008-04-01 |
| Completed | A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis (TB) Subunit Vaccine in Purified Protein Der Tuberculosis | Phase 1 | 2007-09-01 |
| Completed | Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HI HIV Infections | Phase 1 | 2007-01-01 |
| Completed | Rickettsial Genesis to Sarcoidosis in Denmark Sarcoidosis, Rickettsia Infections | — | 2006-09-01 |
| Completed | A Safety and Immunogenicity Trial With an Adjuvanted Tuberculosis(TB) Subunit Vaccine Tuberculosis | Phase 1 | 2005-11-01 |
| Completed | Safety and Immunogenicity of a New Serum-free DTaP-IPVvero Combination Vaccine Active Immunization | Phase 3 | 2003-09-01 |